Livzon Pharma Publishes 2026 Q3 Report, Profit Distribution Proposal and 2026–2028 Shareholder Return Plan

Bulletin Express10-23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) released several key corporate documents on 23 October 2026. The English and Chinese versions of the following materials are now available on both the company’s website (www.livzon.com.cn) and the HKEX platform (www.hkexnews.hk):

• 2026 Third Quarterly Report • Circular dated 23 October 2026 • Notice and Proxy Form for the 2026 Second Extraordinary General Meeting • Profit Distribution Proposal for the first three quarters of 2026 • Shareholder Return Plan covering 2026–2028

Registered shareholders who have elected to receive printed communications will receive hard-copy versions with the current mailing. Shareholders preferring printed materials—or those unable to access electronic versions—can request hard copies free of charge by completing the enclosed request form and returning it to the Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.

To ensure prompt electronic delivery of future corporate communications and actionable documents, shareholders are advised to provide or update a functional email address via the same request form. Until a valid email address is on record, all notices of publication and actionable documents will be sent in printed form.

Enquiries can be directed to Tricor Investor Services Limited’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding public holidays). Livzon Pharma’s board secretary, Liu Ning, signed the notice on behalf of the board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134437734?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-23 17:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134437734","market":"us","top_or_hot":-1,"title":"Livzon Pharma Publishes 2026 Q3 Report, Profit Distribution Proposal and 2026–2028 Shareholder Return Plan","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) released several key corporate documents on 23 October 2026. The English and Chinese versions of the following materials are now available on both the company’s website (www.livzon.com.cn) and the HKEX platform (www.hkexnews.hk):</p>\n<p>• 2026 Third Quarterly Report  \n• Circular dated 23 October 2026  \n• Notice and Proxy Form for the 2026 Second Extraordinary General Meeting  \n• Profit Distribution Proposal for the first three quarters of 2026  \n• Shareholder Return Plan covering 2026–2028</p>\n<p>Registered shareholders who have elected to receive printed communications will receive hard-copy versions with the current mailing. Shareholders preferring printed materials—or those unable to access electronic versions—can request hard copies free of charge by completing the enclosed request form and returning it to the Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.</p>\n<p>To ensure prompt electronic delivery of future corporate communications and actionable documents, shareholders are advised to provide or update a functional email address via the same request form. Until a valid email address is on record, all notices of publication and actionable documents will be sent in printed form.</p>\n<p>Enquiries can be directed to Tricor Investor Services Limited’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding public holidays). Livzon Pharma’s board secretary, Liu Ning, signed the notice on behalf of the board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Publishes 2026 Q3 Report, Profit Distribution Proposal and 2026–2028 Shareholder Return Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Publishes 2026 Q3 Report, Profit Distribution Proposal and 2026–2028 Shareholder Return Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-23 17:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) released several key corporate documents on 23 October 2026. The English and Chinese versions of the following materials are now available on both the company’s website (www.livzon.com.cn) and the HKEX platform (www.hkexnews.hk):</p>\n<p>• 2026 Third Quarterly Report  \n• Circular dated 23 October 2026  \n• Notice and Proxy Form for the 2026 Second Extraordinary General Meeting  \n• Profit Distribution Proposal for the first three quarters of 2026  \n• Shareholder Return Plan covering 2026–2028</p>\n<p>Registered shareholders who have elected to receive printed communications will receive hard-copy versions with the current mailing. Shareholders preferring printed materials—or those unable to access electronic versions—can request hard copies free of charge by completing the enclosed request form and returning it to the Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.</p>\n<p>To ensure prompt electronic delivery of future corporate communications and actionable documents, shareholders are advised to provide or update a functional email address via the same request form. Until a valid email address is on record, all notices of publication and actionable documents will be sent in printed form.</p>\n<p>Enquiries can be directed to Tricor Investor Services Limited’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding public holidays). Livzon Pharma’s board secretary, Liu Ning, signed the notice on behalf of the board.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1134437734","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134437734","pubTimestamp":1792746042,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) released several key corporate documents on 23 October 2026. The English and Chinese versions of the following materials are now available on both the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药发布2026年第三季度报告、利润分配方案及2026-2028年股东回报计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) released several key corporate documents on 23 October 2026. The English and Chinese versions of the following materials are now available on both the company’s website (www.livzon.com.cn) and the HKEX platform (www.hkexnews.hk):\n• 2026 Third Quarterly Report  \n• Circular dated 23 October 2026  \n• Notice and Proxy Form for the 2026 Second Extraordinary General Meeting  \n• Profit Distribution Proposal for the first three quarters of 2026  \n• Shareholder Return Plan covering 2026–2028\nRegistered shareholders who have elected to receive printed communications will receive hard-copy versions with the current mailing. Shareholders preferring printed materials—or those unable to access electronic versions—can request hard copies free of charge by completing the enclosed request form and returning it to the Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.\nTo ensure prompt electronic delivery of future corporate communications and actionable documents, shareholders are advised to provide or update a functional email address via the same request form. Until a valid email address is on record, all notices of publication and actionable documents will be sent in printed form.\nEnquiries can be directed to Tricor Investor Services Limited’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding public holidays). Livzon Pharma’s board secretary, Liu Ning, signed the notice on behalf of the board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134437734","isCrawlerRequest":true}